Braidwell LP Natera, Inc. Transaction History

Braidwell LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$43.4 - $62.52 $6.11 Million - $8.8 Million	-140,706 Reduced 12.21%	1,012,145 $44.8 Billion
Q2 2023 Aug 14, 2023	BUY	$47.08 - $55.16 $8.03 Million - $9.41 Million	170,610 Added 17.37%	1,152,851 $56.1 Billion
Q1 2023 May 15, 2023	SELL	$36.57 - $58.29 $23.4 Million - $37.2 Million	-638,771 Reduced 39.41%	982,241 $54.5 Billion
Q4 2022 Feb 14, 2023	BUY	$34.17 - $47.91 $55.4 Million - $77.7 Million	1,621,012 New	1,621,012 $65.1 Billion

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Braidwell LP, based on Form 13F filings with the SEC.

Stay updated on Braidwell LP with notifications on news.